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Nonpregnant and Pregnant Women, Infants, and Children:
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Background: Acute excess iodine intake can damage the thyroid, but the effects of chronic excess iodine intake
are uncertain. Few data exist for pregnant and lactating women and infants exposed to excessive iodine intake.
Methods: This was a multicenter cross-sectional study. At study sites in rural Kenya and urban Tanzania
previously reporting iodine excess in children, urinary iodine concentration (UIC), thyrotropin, total thyroxine,
and thyroglobulin (Tg) were measured in school-age children (SAC), women of reproductive age, pregnant
(PW) and lactating women, and breast-feeding and weaning infants. In a national study in Djibouti, UIC was
measured in SAC and PW. At all sites, daily iodine intake was estimated based on UIC, and iodine concen-
tration was measured in household salt and drinking water.
Results: The total sample size was 4636: 1390, 2048, and 1198 subjects from Kenya, Tanzania, and Djibouti,
respectively. In Kenya and Tanzania: (i) median UIC was well above thresholds for adequate iodine nutrition in
all groups and exceeded the threshold for excess iodine intake in SAC; (ii) iodine concentrations >40 mg of
iodine/kg were found in approximately 55% of household salt samples; (iii) iodine concentrations ‡10 lg/L
were detected in 9% of drinking water samples; (iv) Tg was elevated in all population groups, but the
prevalence of thyroid disorders was negligible, except that 5–12% of women of reproductive age had sub-
clinical hyperthyroidism and 10–15% of PW were hypothyroxinemic. In Djibouti: (i) the median UIC was
335lg/L (interquartile range [IQR] = 216–493lg/L) in SAC and 265lg/L (IQR= 168–449lg/L) in PW; (ii)
only 1.6% of Djibouti salt samples (n= 1200) were adequately iodized (>15 mg/kg); (iii) the median iodine
concentration in drinking water was 92lg/L (IQR= 37–158lg/L; n= 77). In all countries, UIC was not sig-
nificantly correlated with salt or water iodine concentrations.
Conclusions: Although iodine intake was excessive and Tg concentrations were elevated, there was little
impact on thyroid function. Chronic excess iodine intake thus appears to be well tolerated by women, infants,
and children. However, such high iodine intake is unnecessary and should be avoided. Careful evaluation of
contributions from both iodized salt and groundwater iodine is recommended before any review of iodization
policy is considered.
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Introduction
Iodine is a constituent of thyroid hormone and is es-sential for normal growth and development. Iodine intake
and thyroid gland function have a U-shaped relationship, that
is, both inadequate and excessive intake may affect normal
thyroid function and increase the risk of morbidity (1–3).
Optimal population iodine nutrition is defined as a median
urinary iodine concentration (UIC) of 100–299lg/L for
school-age children (SAC) and 150–499 lg/L for pregnant
women (PW) (4). Universal salt iodization (USI) has had
remarkable success worldwide, and although 112/143 coun-
tries with data in SAC report UIC within the optimal range,
iodine intake is excessive in 11 countries (5).
Excess iodine intake may arise from the consumption of
excessive seaweed, dietary supplements, or over-iodized salt
(6–11). Recent data from Somalia (8), without a salt iodiza-
tion program in place, suggest iodine-rich groundwater may
be another cause of excess intake. Distinct geographical
pockets of naturally occurring elevated water iodine con-
centrations have been documented in a number of countries
(6,11–14). Iodine intake in excess of daily requirements is
generally well tolerated by the healthy thyroid (9,15). How-
ever, both acute and chronic excessive iodine intake have
been associated with thyroid disorders in susceptible indi-
viduals (9,15,16), but data are scarce, particularly in vul-
nerable populations such as pregnant and lactating women,
and infants (9).
Thyroglobulin (Tg), the thyroid-specific glycoprotein on
which iodine is stored and thyroid hormone is formed, can be
measured in serum or on dried blood spots (DBS) and is a sen-
sitive biomarker of iodine status (17–19). Tg is recommended
in addition to spot urine samples for UIC in population surveys
of iodine status (4). Collection of DBS-Tg is a field-friendly
method (20), and DBS-Tg is a sensitive biomarker for borderline
excessive iodine intake in SAC and PW (2,3).
This study aimed to assess the effects of a chronic exposure
to iodine intake above recommended levels on Tg, thyroid
function, and subclinical and overt thyroid disorders in wo-
men, infants, and children. To do this, two regions were se-
lected in Kenya and Tanzania that previously reported high
iodine intake in SAC, and a national survey was performed in
Djibouti, a country suspected to have iodine-rich ground-
water due to its location in Northeast Africa (11). The hy-
pothesis was that chronic excess iodine intake in these
regions would cause an increase in thyroid disorders in the
population.
Methods: Kenya and Tanzania
Study design and study sites
A cross-sectional study was conducted of six population
groups at sites in rural Eastern Kenya (Kibwezi, Makueni
County) and urban Tanzania (Kinondoni District, Dar es
Salaam) with previously documented iodine excess in SAC
(median UIC >300lg/L) (2,21).
Kenya. Since its inception in 1970, salt iodization in
Kenya has been remarkably successful, with a 99.5% house-
hold coverage of iodized salt recorded in 2014 (22). In 2003–
2004, the national median UIC in SAC was 118lg/L (23),
though intake was as high as 477lg/L in Nairobi. In response,
in 2010, the government reduced the recommended salt iodine
concentration from 100 to 30–50 mg/kg (24). In 2011, the
Kenyan National Micronutrient Survey reported a national
median UIC of 208lg/L (interquartile range [IQR]= 108–
333lg/L) in SAC; 30% had a UIC >300lg/L (24), but intake
varied highly nationwide. A study in Kibwezi District recorded
a median UIC of 624lg/L (IQR= 437–939lg/L) in SAC
(n= 342) (21); 90% had a UIC >300lg/L, and 21% had an
elevated serum Tg (>40lg/L). Daily salt intake was estimated
to be 4 g/child/day, and the mean iodine content in household
salt samples was 64 mg/kg (n= 18), suggesting additional di-
etary iodine contributions from another source. Limited data
on groundwater iodine concentrations in Kenya have generally
recorded concentrations <10lg/L (25,26).
Tanzania. Salt iodization was introduced in Tanzania in
1995 (27), and it was mandated at 20–80 mg/kg (28). In 2010, the
national coverage of iodized salt was 82% (29), but this dropped
to 64% in 2014, and coverage was uneven across the country
(29). The 2010 national survey reported a median UIC in women
of reproductive age (WRA) of 160lg/L, but high intake was
observed in urban areas (median UIC 375lg/L) (30). In Ki-
nondoni District of Dar es Salaam, the median UIC in SAC was
338lg/L (range 6–1883lg/L) and the geometric mean– stan-
dard deviation (SD) of DBS-Tg was 17.6–14.3lg/L (2).
At both country sites, iodized salt is widely available, and
bouillon cubes or powder made with iodized salt are used to
flavor foods. Iodine-containing dietary supplements are
generally unavailable. Subsidized fortified maize meal (vi-
tamin A, thiamin, riboflavin, niacin, pyridoxine, folic acid,
iron, and zinc) and fortified cooking oil (vitamin A) are sta-
ples in the diet.
Subjects
Following a standard protocol for both study sites, partici-
pants were recruited from six different population groups: (i)
SAC (aged 6–12 years); (ii) nonpregnant non-lactating WRA
(aged 18–44 years); (iii) PW (aged 18–44 years); (iv) lactating
women (aged 18–44 years); (v) exclusively breastfed infants
(‘‘breast-feeding infants’’; aged 0–6 months); and (vi) infants
and children 7–24 months of age receiving both breast milk
and complementary foods (‘‘weaning infants’’). SAC and
WRA, and lactating women and breast-feeding infants were
recruited as pairs where possible.
The inclusion criteria for all subjects were: (i) residence at
the study site for ‡12 months; (ii) apparently healthy and no
reported treatment for chronic disease; (iii) no family or
personal history of thyroid disease; (iv) no exposure to
iodine-containing contrast agent or medication within the last
year (since birth if <12 months, except for iodine disinfectant
used at birth). Additional criteria for women and infants
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stated that WRA should not currently be pregnant or breast-
feeding, and PW or lactating women must have had a healthy,
singleton pregnancy. Infants (breast-feeding infants and
weaning infants) must have been born at full term (gestation
38–42 weeks) from a singleton pregnancy, and not have a
weight-length Z-score <–3 or mid-upper arm circumference
(MUAC) <115 mm (31). Any infant identified as such was
excluded from the study and referred for medical assistance.
PW were recruited at all stages of gestation; mean – SD
gestational age at enrolment was 27 – 8.5 weeks for Kenyan
women and 25 – 7.0 weeks in Tanzania ( p= 0.24). Sample
sizes were greater for trimesters two and three compared to
the first trimester (Kenya: 8.4%, 31.3%, and 60.2%; Tanza-
nia: 5.3%, 53.4%, and 41.2%; of total sample sizes for tri-
mesters 1, 2 and 3, respectively).
As a population-based study with a cross-sectional sam-
pling frame, the study estimated the number of subjects
needed to establish the median UIC around which the pop-
ulation varies according to Lemeshow et al. (32), and that
needed to estimate the proportion of SAC with an elevated Tg
on DBS (>40 lg/L) using the equation of Naing et al. (33).
Using previous data from Kinondoni, Tanzania (2), and al-
lowing for a 15% margin for participant withdrawal and loss
to follow-up, it was calculated that a sample size of 300
participants per group per study site would allow these out-
comes to be estimated with 90% confidence and 5% error.
Ethical approval was obtained from the Ethics Review
Committee of the ETH Zurich (Zurich, Switzerland), the
National Institute for Medical Research in Tanzania, and the
Kenyatta University Ethics Review Committee in Kenya.
Participants were recruited following information sessions:
in schools, parents of students in applicable class age groups
were invited to attend an information session; in participating
health centers and dispensaries, a similar session was held at
the start of pre- or antenatal clinics on appropriate days.
Participation was voluntary, and written informed consent
was obtained from every participant at entry to the study
(parent or legal guardian for breast-feeding infants and
weaning infants; parent and child for participation of SAC).
All collected data were anonymized before analysis. In
Kenya, participants were recruited from three health centers,
one hospital, and three schools in Kibwezi District; in Tan-
zania, participants were recruited from four health dispen-
saries and five schools in Kinondoni District.
Study procedures
The study was conducted between January and April 2016.
Anthropometrics. Upon entry to the study, anthropo-
metric assessment of all participants was conducted using
standard methods (34). Participants were instructed to re-
move shoes where applicable, empty pockets, and wear light
clothing. Body weight was measured to the nearest 0.1 kg
using a Seca digital scale (Seca 874) or Seca baby scale (Seca
384) calibrated with standard weights (Seca, Hamburg,
Germany). Length or height was measured to the nearest
0.1 cm using a pull-down measuring tape or UNICEF length
board (UNICEF Supply Division). Head circumference was
measured to the nearest 0.1 cm using a commercial tape
measure. Weight and height were measured for all partici-
pants, and head circumference for infants and children.
Weight-for-age (WAZ) and length or height-for-age (HAZ)
Z-scores were calculated for infants and children based on the
World Health Organization (WHO) age- and sex-specific
Child Growth Standards (35), using Anthro and AnthroPlus
v3.2.2 (World Health Organization, Geneva, Switzerland).
Body mass index (BMI) was calculated for WRA and lac-
tating women by dividing the weight (kg) by the square of the
height (m2). At inclusion, WLZ was estimated using age- and
sex-specific WHO growth charts (35) for all breast-feeding
infants, and the MUAC of weaning infants was measured
using a 6- to 60-month-old MUAC tape (UNICEF Supply
Division). Median Z-scores in included infants were other-
wise all greater than the WHO cutoff of <–2 to indicate low
WAZ or HAZ (35).
Questionnaire. A questionnaire was administered to all
participants to ascertain general dietary habits, including
general consumption of native iodine-rich foods, knowledge
and use of iodized salt for both participant and household, use
of dietary supplements, and cigarette smoking in women.
Additional questions for breast-feeding infants and their lac-
tating mothers covered iodine exposure at birth and feeding
practices, and for weaning infants, weaning practices and
complementary food intake, particularly weaning foods forti-
fied with iodine.
Spot urine sample. A spot urine sample was collected
from all participants at any time of day except the first morning
void in order to determine iodine status by UIC. SAC, WRA,
PW, and lactating women were given a plastic cup and were
asked to provide around 20 mL of fresh midstream urine.
Where mother–child pairs were sampled, samples were col-
lected on the same day. Samples from breast-feeding infants
were collected using a pad collection system (Sterisets New-
castle Urine Collection Pack, Sterisets International B.V., The
Netherlands). The pad was placed inside a disposable nappy
and checked regularly until wet with urine (but not soiled with
feces) when it was then removed and >3 mL of urine ex-
pressed. Mothers of weaning infants were invited to use the
same system for their infants or, if preferred, supplied with a
clean plastic cup to collect approximately 20 mL of midstream
urine. The urine samples were aliquoted (at least 1 mL per
aliquot) into three 2.0 mL Eppendorf tubes (Eppendorf,
Hamburg, Germany) without filtration, transported in a cool
box from the place of the collection to the local storage freezer,
transported frozen to the laboratory, and stored frozen at
-20C until analysis.
Estimated iodine intake. Daily iodine intake was esti-
mated using the UIC for each population group except for
lactating women (36), using average urine volumes of 1 L for
SAC, 1.5 L for WRA, 1.8 L for PW (37), and 500 mL for both
infant groups (38). Dietary iodine excretion was set at 90%
(37).
DBS. Trained laboratory technicians collected finger-
prick samples from SAC and women or heel-prick samples
from infants onto DBS filter paper collection cards (IDBS-
226; PerkinElmer, CT). Blood spots contained 50 lL of
whole blood. After collection, cards were dried at room
temperature and placed in sealed plastic bags with a desic-
cant, and then stored frozen at -20C until analysis. DBS-Tg,
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DBS-thyrotropin (TSH), and DBS-total thyroxine (TT4)
were measured to assess prevalence of thyroid dysfunction.
Breast milk. To assess breast milk iodine concentration
(BMIC) and provide a complete assessment of the iodine
status of lactating women, a breast milk sample was collected
from lactating women enrolled in Kenya. A 10 mL foremilk
sample was obtained by manual expression into a plastic
container (39). Breast milk samples were transported cold
from the place of collection, separated into aliquots, frozen at
-20C, and shipped frozen from the study sites to the ETH
Zurich for analysis.
Salt. A household salt sample for determination of iodine
content was collected from WRA–SAC pairs enrolled in the
study at both sites. During pre-study information sessions
held at the respective schools, parents were requested to bring
approximately 50 g of household salt to their visit in a clean
plastic container. The salt samples were stored tightly closed
at room temperature without drying until analysis.
Drinking water. In Kenya, 20 mL of household water was
collected that was usually drunk and used for culinary pur-
poses. WRA–SAC pairs were asked to bring a sample in a
clean plastic container. The water samples were aliquoted
into three 2.0 mL Eppendorf tubes and frozen at -20C until
analysis. Furthermore, groundwater sources were opportu-
nistically sampled in Kenya in a 25 km radius around the
study site, including from bore holes, wells, springs, a local
river, and piped water outlets, reportedly fed from a natural
source approximately 10 km from the study site (Umani
Springs, Chyulu Hills National Park) and treated with chlo-
rine disinfectants. No samples could be taken directly from
this source, uniquely from the outlets. Water was taken from
each site in triplicate in 20 mL clean, iodine-free plastic
containers, from which each sample was aliquoted into three
2.0 mL Eppendorf tubes without filtration and frozen at
-20C until analysis. Bore holes were pumped and allowed to
run for a few minutes before sampling to obtain fresh water.
In Tanzania, a drinking water sample was collected from a
subset of 30 students per school (n = 114). Selection of these
students was made with the help of teachers in order to permit
collection of water from groundwater sources in the imme-
diate vicinity of the school. Samples were aliquoted as pre-
viously described.
Methods: Djibouti
Study design and study sites
The study in Djibouti was cross-sectional and nationally
representative. Recruitment was from five districts each from
both within and outside of Djibouti City. SAC were selected
from representative households each assigned an identifica-
tion number in the 10 districts; PW were recruited from
health center records (n = 130 for Djibouti City, 13 health
centers; n = 100 for the rest of the country, 20 per district).
Sampling and study design was in accordance with the Na-
tional Statistics and Demographic Studies Department of
Djibouti (Direction de la Statistique et des E´tudes De´mo-
graphiques [DISED]).
Subjects
In total, 985 SAC aged 6–13 years and 213 PW aged 18–43
years in their second or third trimester were recruited.
Study procedures
Samples were collected between November and December
2015. Sample collection did not coincide with the rainy pe-
riod, though the Republic of Djibouti is an arid country with
an annual rainfall of <200 mm (40). The study was conducted
in participation with the Nutrition Service of the Republic of
Djibouti Ministry of Health, Mother and Child Health De-
partment (Ministe`re de la Sante´, Direction de la Sante´ de la
Me`re et de l’Enfant), Service Nutrition), which granted ap-
proval for conduct of the study, and DISED.
Spot urine sample. Following written informed consent,
a spot urine sample was collected from all participants at any
time of day except the first morning void. Participants were
asked to provide approximately 20 mL of fresh, midstream
urine into a plastic cup. Samples were aliquoted into three
2.0 mL Eppendorf tubes without filtration, transported in a
cool box from the place of collection to the local storage
freezer, transported frozen to the laboratory, and stored fro-
zen at -20C until analysis.
Salt. All subjects were requested to provide a sample of
household salt to assess iodine content. Participants were
requested to bring approximately 50 g of household salt to
their visit in a clean plastic container. The salt samples were
stored tightly closed at room temperature, without drying,
until analysis.
Drinking water. Seventy-seven potable water samples were
collected from drinking water outlets in five regions (Djibouti
city-Arta, Obock, Tadjourah, Dikhil, and Ali Sabieh) to assess
iodine content. Samples were representative of the nine poten-
tial types of drinkingwater in Djibouti. Approximately 25 mL of
water was collected from each source into clean plastic con-
tainers, which was later aliquoted unfiltered into three 2.0 mL
Eppendorf tubes and frozen at -20C until analysis. Bore holes
were allowed to run for a few minutes before sampling to obtain
fresh water.
Laboratory analyses
All sample collection materials (urine, salt, and water
collection material; test tubes; and urine collection pads)
were tested for iodine contamination (41).
Urinary iodine, salt iodine, and water iodine concentra-
tions. The Tanzania Food and Nutrition Centre (TFNC; Dar
es Salaam, Tanzania) measured iodine concentrations in ur-
ine and salt from Tanzania and Djibouti using a modified
version of the Sandell–Kolthoff method (42), with an inter-
assay variation of 18.3% for lower controls (41– 7.5 lg/L;
n = 28), 10.5% for mid-range controls (88 – 9.2 lg/L; n = 28),
and 7.7% for high controls (180 – 14 lg/L; n= 28). All other
urine, salt, and water samples were measured at the Human
Nutrition Laboratory (Institute of Food, Nutrition and Health,
ETH Zurich), using the same method, with an inter-assay
variation for lower controls of 4.6% (67– 3 lg/L; n = 71) and
EXCESS IODINE INTAKE INCREASES TG CONCENTRATIONS 1201
D
ow
nl
oa
de
d 
by
 K
A
O
H
SI
U
N
G
 M
ED
IC
A
 U
N
IV
ER
SI
TY
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 1
0/
05
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
for high controls of 3.2% (205 – 7 lg/L; n = 71). The same
ETH Zurich laboratory-specific control material was ana-
lyzed at the TFNC with an inter-assay variation of 9.2% for
lower controls (62 – 6 lg/L; n = 18) and 3.5% for high con-
trols (190– 7 lg/L; n = 18). Both laboratories successfully
participate in the Program to Ensure the Quality of Urinary
Iodine Procedures (U.S. Centers for Disease Control and
Prevention, Atlanta, GA), including its quarterly external
validation.
A subset of water samples was externally validated by the
Inorganic Geochemistry laboratories at the British Geologi-
cal Survey (Nottingham, United Kingdom) by inductively
coupled plasma mass spectrometry (ICP-MS; Agilent 8900;
Agilent Technologies, Santa Clara, CA), with high agree-
ment between methods (R = 0.999, p < 0.001).
Adequate iodine status in SAC, WRA, breast-feeding in-
fants, and weaning infants was defined as a median UIC
‡100lg/L (4). In PW, adequacy was set at ‡150 lg/L and
excess at ‡500lg/L (4). In SAC, excessive iodine intake was
defined as a median UIC ‡300lg/L; no such threshold has
been defined for nonpregnant adults or infants. UIC was not
used to determine iodine status in lactating women (36).
The salt iodine concentration was defined as low at
<15 mg/kg, adequate at 15–40 mg/kg, and high at >40 mg/kg
(4); water with iodine ‡10 lg/L was considered as iodine
concentrated (43).
Thyroid function. DBS-Tg was measured at the Human
Nutrition Laboratory of the ETH Zurich using a DBS-Tg
enzyme-linked immunosorbent assay, as described elsewhere
(44). Serum control samples (Liquicheck Tumor Marker
Control, LOT.23911, 23912, 23913; Bio-Rad, Hercules, CA)
were used as standards for the DBS Tg assays. In-house DBS
samples were used for quality control, and the inter-assay
variation for lower controls was 18.3% (25.8– 4.7lg/L;
n= 96), 12.0% at mid-range controls (51.7– 6.2lg/L; n= 96),
and 12.7% for high controls (72.0– 9.1lg/L; n= 31). Assay-
specific reference ranges for DBS-Tg are 4–40lg/L in SAC
and 0.3–43.5lg/L in PW, with risk of an excessive intake in
that population defined as >3% of values lying above the upper
threshold. No reference values for this DBS-Tg assay have
been defined for nonpregnant adults or infants.
TSH and TT4 concentrations were measured at the University
Children’s Hospital Zurich (Swiss Newborn Screening Labora-
tory and Children’s Research Center, Zurich, Switzerland) using
an automated time-resolved fluoroimmunoassay method and a
Genetic Screening Processor (GSP) machine (2021-0010; Per-
kinElmer, Turku, Finland) and related GSP Neonatal TSH/T4
kits (PerkinElmer). Kit-specific controls were used for the
analysis, with an intra-assay variability for TSH of 9.1% at
0.92–0.08 mIU/L (n=26) and 6.8% at 10.20–0.69 mIU/L
(n=30) and for TT4 of 7.4% at 49.5–3.6 nmol/L (n=28), 14.0%
at 106.2–14.9 nmol/L (n=28), and 6.0% at 221.1–13.3 nmol/L
(n=28). American Thyroid Association (ATA) recommended
thresholds (45–48) were used to adapt kit-specific labora-
tory reference ranges and applied to estimate the prevalence
of thyroid dysfunction in the study population. For infants,
SAC, and WRA, the following thresholds were used. TSH: 0–7
days, 0.1–10.5 mIU/L; 7–21 days, 0.1–5.3 mIU/L; 21–60
days, 0.1–5.0 mIU/L; 60–155 days, 0.1–4.5 mIU/L; ‡155 days,
0.1–3.7 mIU/L. TT4 : 0–7 days, 114–245 nmol/L; 7–21 days,
123–170 nmol/L; 21–60 days,84–170 nmol/L; 60–155 days, 80–
165 nmol/L; ‡155 days, 65–165 nmol/L. In the absence of ref-
erence ranges for lactating women, the adult reference range was
used (0.1–3.7 mIU/L). This reference range was also applied to
PW in the second and third trimesters. For PW in the first tri-
mester, the upper limit of the DBS-TSH assay was lowered by
18% to 3.0 mIU/L following the most recent ATA recommen-
dations (48). For DBS-TT4 in PW in gestational weeks 1–6, the
assay specific normal adult reference range of 65–165 nmol/L
was applied, increasing the upper limit by 5% per week from
week 7 (48). From week 16, the nonpregnant adult reference
range was multiplied by 1.5, and the resulting thresholds of 97.5–
247.5 nmol/L were used thereafter (48). Data were recorded as
being either lower than or elevated over these reference ranges.
Then, the following diagnostic criteria were applied to the data to
estimate the prevalence of thyroid dysfunction. Subclinical
hypothyroidism: elevated DBS-TSH, normal DBS-TT4; overt
hypothyroidism: elevated DBS-TSH and low DBS-TT4 or DBS-
TSH >10 mIU/L and normal TT4; subclinical hyperthyroidism:
low DBS-TSH and normal DBS-TT4; overt hyperthyroidism:
low DBS-TSH and elevated DBS-TT4; and isolated hypothyr-
oxinemia: normal DBS-TSH and low DBS-TT4.
BMIC. BMIC was measured at the Human Nutrition
Laboratory of the ETH Zurich by multi-collector ICP-MS
(Finnigan NEPTUNE; Thermo Fisher Scientific, Waltham,
MA) with the use of isotope dilution analysis with 129I and
Tellurium for mass bias correction (39). Samples were pre-
pared with the use of tetramethylammonium hydroxide
(Tama, Kawasaki, Japan) for iodine extraction at 90C for
180 min. Whole-milk powder standard reference material
(NIST SRM1549a Whole Milk Powder; National Institute of
Standards and Technology, Gaithersburg, MD) was used as
an external control. The mean – SD iodine concentration of
the standard reference material (n = 6) was 3427– 80 lg/kg
(CV: 2%), which is in agreement with the certified acceptable
range (3040–3640 lg/kg).
Statistical analyses
Statistical analyses were performed using Microsoft Excel
2011 (Microsoft Corp., Redmond, WA) and IBM SPSS
Statistics for Windows v23 (IBM Corp., Armonk, NY). UIC
and DBS-Tg were the co-primary outcomes, and TSH and
TT4 on DBS were the secondary outcomes. Data normality
was assessed using Kolmogorov–Smirnov and Shapiro–Wilk
tests, a skewness of <1, and visually using Q–Q and P–P
plots; non-normal data were log-transformed where possible.
Outlying data were checked for validity and corrected where
possible or removed where there were obvious typographical
errors (e.g., 200 cm height) that could not be resolved.
Otherwise, no outliers were removed. Unless specified, all
normally distributed data are described as mean – SD, and
nonparametric data are described as median (IQR). Data were
bootstrapped (n = 1000) where applicable to obtain robust
confidence intervals.
Group differences were assessed between continuous
nonparametric variables using the Kruskall–Wallis test with
Bonferroni correction, and by one-way analysis of variance
with Bonferroni correction for data able to be appropriately
log transformed. Spearman’s rho was used to test nonpara-
metric associations with ordinal data. The association be-
tween UIC and other secondary outcome parameters was
1202 FAREBROTHER ET AL.
D
ow
nl
oa
de
d 
by
 K
A
O
H
SI
U
N
G
 M
ED
IC
A
 U
N
IV
ER
SI
TY
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 1
0/
05
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
assessed using regression analyses on log data with relevant
covariates. Group differences for prevalence were compared
using the chi-square test, followed by the Z-test to check for
significant differences between the individual values, ap-
plying Bonferroni correction. Separate subgroup analyses
were undertaken in PW based on gestational week: PW who
enrolled at (i) £20 weeks’ gestation (n= 42 in Kenya and
n = 104 in Tanzania), corresponding to the time before which
the fetal thyroid is not capable of iodine organification, and
(ii) £36 weeks’ gestation (n = 116 in Kenya and n = 300 in
Tanzania).
In Djibouti, the association between water iodine con-
centration and UIC was assessed where both water iodine
concentration and UIC were available. To model influences
on UIC in addition to potential effects of water consumption
further, the distance from the coast was estimated for each
location as a proxy for the potential influence of seafood
consumption on iodine intake, and the potential influence of
main bedrock type per location on the corresponding iodine
content of the water source was investigated, applicable to
traditional and drilled wells only. Rock types were taken from
the Global Lithological Map (GLiM) v1.0 (University of
Hamburg, Hamburg, Germany) (49). The trends between
water source and iodine concentration were also evaluated at
each location.
Significance was set at p < 0.05.
Results: Kenya and Tanzania
A total of 3438 participants from rural Kenya (n = 1390)
and urban Tanzania (n = 2048) were sampled. Three infants
in Kenya were excluded because of severe acute malnutri-
tion. General characteristics of all participants at inclusion
are shown in Table 1. HAZ and WAZ in SAC were lower at
the rural site in Kenya compared to the urban site in Tanzania
( p = 0.014 and p < 0.0001, respectively). The BMI of non-
pregnant women was also lower at the rural site compared to
the urban site ( p < 0.0001).
Salt iodine and water iodine concentration
The self-reported household iodized salt use was 71%
in Kenya and 84% in Tanzania ( p= 0.91). The measured
median salt iodine concentration was 43 mg/kg (IQR = 32–
54 mg/kg; n = 195) in Kenya and 44 mg/kg (IQR = 35–53 mg/
kg; n = 274) in Tanzania ( p = 0.91): 44% (total n = 195) of salt
samples in Kenya and 32% (total n = 274) in Tanzania were
adequately iodized (15–40 mg/kg). Two samples from Tan-
zania contained no iodine (<5 mg/kg). From the remaining
samples, 0.5% of samples in Kenya and 2% in Tanzania were
below recommended levels (<15 mg/kg); 55% and 56% of
the samples contained >40 mg/kg, respectively.
In Kenya, household water brought by SAC–WRA pairs
(n = 177) was generally low in iodine, with 47% of samples
measuring 0lg/L. Yet, 14% of samples measured >10lg/L,
and one sample from a natural spring measured 2943lg/L (a
possible contamination). The mean – SD iodine concentra-
tion in these samples was 20 – 221lg/L, and the median was
1 lg/L (IQR = 0–4lg/L). Samples originated from harvested
rain water (n = 1), bore holes (n = 1), river water (n = 5), wells
(n = 1), springs (n = 23), and piped water outlets (n= 46). In
Tanzania, household water samples (n = 114) collected from
subsets of students from each of the four schools ranged from
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0 to 596lg/L. The mean – SD iodine concentration from
Tanzania was 24–78lg/L; the median was 4lg/L (IQR=0–11
lg/L). There was no difference in the water iodine concentration
between the Tanzanian water samples and the Kenyan
household water samples ( p = 0.179, excluding the poten-
tially contaminated sample). The iodine concentration in the
Kenya groundwater samples ranged from 3 to 717 lg/L, with a
mean – SD water iodine concentration of 228– 159lg/L in
the bore holes (n= 23), 224lg/L in the wells (n = 2), 20 – 2
lg/L in the springs (n = 4), 107 lg/L in the river (n= 1), and
7 – 3lg/L (n = 4) in water from piped outlets (Supplementary
Table S1; Supplementary Data are available online at www
.liebertpub.com/thy).
Urinary iodine, estimated iodine intake, and BMIC
The median UIC was well above the thresholds for ade-
quate iodine nutrition in all population groups and exceeded
the threshold for excess iodine intake (‡300 lg/L) in SAC
but not in PW (Fig. 1). Estimated iodine intake is described
in Table 2. The UIC of the SAC or WRA was not signifi-
cantly correlated with salt iodine concentration or with the
household or collected water iodine concentrations in any
country.
The median UIC in lactating women was 245 lg/L
(IQR= 279–886lg/L) in Kenya and 192lg/L (IQR= 120–297
lg/L) in Tanzania ( p= 0.003), significantly lower than the
median UIC in WRA for both study sites ( p < 0.001; Fig. 1).
The median BMIC for lactating women in Kenya was 240lg/
L (IQR = 173–347 lg/L; n = 126), and positively correlated
with their UIC as well as the UIC of their breastfed infants
( p < 0.01).
Thyroid function
In Kenya, the median DBS-Tg of of SAC was 37 lg/L
(IQR = 25–53 lg/L), and in Tanzania, it was 32 lg/L (IQR =
22–45 lg/L; p= 0.001): 46% and 31% of children had ele-
vated DBS-Tg concentrations, respectively (Table 2). The
prevalence of elevated DBS-Tg concentrations in PW was
approximately half that of SAC: 20% in Kenya and 16% in
Tanzania (Table 2). Gestational week was negatively corre-
lated with UIC in Kenyan women ( p< 0.05) and positively
correlated with DBS-Tg in Kenya ( p < 0.05) and Tanzania
( p < 0.01). Median DBS-Tg values were >50 lg/L in both
breast-feeding infants and weaning infants in both countries.
The median (IQR) thyroid hormone concentration (DBS-
TSH, DBS-TT4) and the prevalence of subclinical and
FIG. 1. Urinary iodine concentration (lg/L) by study site and population group. Error bars denote confidence intervals
(CI) based on 1000 bootstrapped samples. Population iodine sufficiency and excess in school-age children are defined by a
median urinary iodine concentration of ‡100lg/L and ‡300 lg/L, respectively, and, in pregnant women, of ‡150lg/L and
‡500lg/L, respectively (4). Differences within population groups between countries are as follows (Kruskall–Wallis test
with Bonferroni correction). School-age children: Kenya–Tanzania, p = 0.010; Kenya–Djibouti, p < 0.001; Tanzania–
Djibouti, p < 0.001; women of reproductive age: p < 0.001; pregnant women: Kenya–Tanzania, p = 0.005; Kenya–Djibouti,
p = 0.026; Tanzania–Djibouti, p < 0.001; lactating women: p= 0.003; breast-feeding infants: p = 0.185; and weaning infants:
p = 0.009. Median breastmilk iodine concentration for lactating women in Kenya: 240lg/L (interquartile range = 173–
347 lg/L; n = 126).
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clinical thyroid disorders are presented by country and pop-
ulation group in Table 3. The prevalence of subclinical and
overt hypothyroidism and hyperthyroidism was low in all
population groups, except for subclinical hyperthyroidism in
WRA (5% in Kenya and 12% in Tanzania; p < 0.05) and
hypothyroxinemia in PW (10% in Kenya and 15% in Tan-
zania; p > 0.05). The prevalence of hypothyroxinemia in-
creased with trimester in both countries ( p > 0.05).
DBS-Tg correlated with DBS-TSH in SAC ( p < 0.0001)
and PW ( p= 0.001) in Kenya, and in SAC ( p = 0.001), PW
( p < 0.001), breast-feeding infants ( p = 0.002), and weaning
infants ( p = 0.002) in Tanzania. DBS-Tg correlated with
DBS-TT4 in WRA ( p < 0.001), PW ( p = 0.009), and lactating
women ( p= 0.036) in Kenya, and in WRA ( p= 0.027) and
lactating women ( p= 0.049) in Tanzania.
There were no differences between prevalence of thyroid
function disorders with gestational age at 20 weeks, or be-
tween women <36 weeks’ gestation and those approaching
term.
Results: Djibouti
In Djibouti, 1198 subjects were included: 985 SAC and
213 PW from 17 towns, villages, and settlements across the
country.
Salt and water iodine concentration
Only 1.6% of all samples were adequately iodized (15–40
mg/kg). Iodine (‡5 mg/kg) was detected in only 9% of all
household salt samples (n = 1200). Of these, 82% contained
<15 mg/kg and the median of the iodine-containing samples
was 10 mg/kg (IQR = 6–13 mg/kg; n = 104).
Seventy-seven water samples were collected from 21
water outlets, including traditional and drilled wells, public
fountains, and government-managed pipes in the same lo-
cations and additional locations across the country. The
median water iodine concentration was 92lg/L (IQR = 37–
158lg/L); the highest concentration was 647lg/L. There
were no significant differences between water from different
types of water source, bedrock type, or distance from the sea.
UIC and estimated iodine intake
The median UIC suggests excessive iodine intake in SAC
(median UIC 335lg/L; IQR = 216–493 lg/L) but was within
the normal range in PW (median UIC 265 lg/L IQR = 168–
449lg/L; Table 2). The median UIC for SAC and PW was
significantly lower than the median UIC in both Kenya and
Tanzania ( p < 0.001). The estimated iodine intake was
301lg/day and 357 lg /day in SAC and PW, respectively
(Table 2).
There were no significant correlations between water io-
dine concentration and UIC in either group. Similarly, there
were no significant trends between UIC and distance from the
coast or rock type.
Discussion
The results suggest an iodine intake level well above re-
quirements in all population groups at the study sites in
Kenya, Tanzania, and nationally in Djibouti, with the median
UIC in SAC exceeding the WHO threshold for iodine excess
of 300 lg/L (4) at each study site.
Iodine deficiency was historically endemic in Kenya and
Tanzania, but both countries have had USI programs in place
for >20 years. Salt iodine concentrations measured in this
study suggest high coverage of iodized salt in both study
sites, but more than half of the salt samples were over-iodized
(>40 mg/kg). The overall salt iodine concentrations were
Table 2. Median UIC, Estimated Iodine Intake, and Median DBS-Tg by Study Site and Population Group
na UIC (mg/L)
Estimated median
iodine intake (lg/day) n DBS-Tg (mg/L)
% Elevated
DBS-Tg
Kibwezi District, Kenya SAC 284 424c (294–598) 382 253 37.4d (25.0–53.0) 46.2
WRA 293 289e (173–458) 390 213 26.6e (18.9–39.8) —
PW 162 337c (198–505) 546 149 28.1 (19.3–41.3) 20.1
LW 146 245c (279–886) NA 147 21.5 (15.0–31.1) —
BFI 110 546 (323–940) 246 142 51.1c (37.8–64.2) —
WI 250 602c (348–1205) 271 312 56.1c (43.4–74.5) —
Kinondoni District,
Tanzania
SAC 317 520 (329–760) 468 310 32.1 (21.7–44.8) 31
WRA 298 473 (321–689) 639 321 18.1 (12.1–28.8) —
PW 330 422 (270–609) 684 335 25.9 (18.1–36.3) 16.1
LW 363 192 (120–297) NA 366 19.2 (13.9–27.5) —
BFI 208 515 (279–886) 232 341 59.4 (39.8–81.7) —
WI 240 528 (255–952) 238 236 52.2 (35.7–77.4) —
Djibouti SAC 985 334 (126–493) 301 NA
PW 213 264 (168–449) 357
Data are expressed as median (IQR).
aDisparity in sample numbers is due to inability to give sample, inadequate sample, sample loss, or sample deterioration.
bElevated UIC defined as >300lg/L in SAC and >500lg/L in PW (5); elevated DBS-Tg >40 lg/L in SAC and 43.5 lg/L in PW (2,29).
No thresholds have been defined for other groups.
Differences between groups are indicated by superscript letters: cp < 0.05; dp < 0.001; ep < 0.0001 (paired independent samples t-test, for
normal or log-transformed-normal data). Daily iodine intake is estimated using UIC for each population group (except for lactating women)
using average urine volumes of 1 L for SAC, 1.5 L for women of reproductive age, 1.8 L for PW (60), and 500 mL for both infant groups
(61). Iodine excretion was set at 90% (60).
DBS, dried blood spot; NA, not measured; Tg, thyroglobulin; UIC, urinary iodine concentration.
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comparable between the two countries, but the UIC in SAC,
WRA, and PW were consistently higher in Tanzania than
Kenya ( p < 0.001), possibly a reflection of high salt con-
sumption in Tanzania (50), although salt intake was not
measured in this study. Moreover, high groundwater iodine
concentrations were observed in all three study sites, and for
the first time in these countries, it is shown that naturally
occurring high water iodine concentrations may also be a
major contributor to the overall iodine intake, particularly in
Djibouti, and must be considered in national iodine defi-
ciency prevention programs. In 2017, after the completion of
this study, Djibouti inaugurated a new water pipeline from
Ethiopia to provide the arid country with a guaranteed water
supply (51), and iodine intake may concurrently fall.
Elevated Tg concentrations were observed in all popula-
tion groups in Kenya and Tanzania. Tg has been shown, both
in vitro and in vivo, to be a potent regulator of thyroid
function at high iodine intake (52), including suppressed
expression of the basolateral sodium–iodine symporter (53)
and its counterpart on the apical membrane, pendrin (52).
Megalin, an endocytic transporter protein, binds colloidal Tg
with a high affinity and facilitates its transcytosis through the
thyrocyte, avoiding lysosomal degradation and allowing re-
lease into the circulation (54). This mechanism may regulate
and prevent the liberation of excessive thyroid hormone un-
der changes in iodine intake and may explain why, in the
current populations, Tg is elevated but little thyroid hormone
fluctuation was observed. The Tg concentrations were cor-
related with TSH in most groups. Yet, TSH remained within
the reference ranges. TSH is the central regulator of thyroid
function and controls the synthesis of Tg and its secretion
onto the colloidal surface where iodination takes place (53).
An elevated Tg seen in response to increasing iodine intake
but coupled with normal TSH suggests that in addition to
TSH, Tg may contribute to thyroidal adaptation under ex-
tremes of iodine intake and may play a regulatory role in
thyroid function. Previous studies suggest Tg is a sensitive
marker of iodine status (1–3,14,17,19); the present data also
support these findings at excessive iodine intake.
An increased prevalence of thyroid disorders was not ob-
served, except for WRA who were affected by a 5% and 12%
prevalence of subclinical hyperthyroidism in Kenya and
Tanzania respectively, and isolated maternal hypothyrox-
inemia ranging from 10% to 15% in PW (Table 3). Subclinical
hyperthyroidism was defined by a low TSH concomitant with
a TT4 within the reference range, following ATA guidelines
(45–48). In the U.S. National Health and Nutrition Examina-
tion Survey, 1.8% of participants had a TSH <0.4 mIU/L.
However, split racially, the proportions were significantly
uneven: 4% of black people compared to 1.4% of white people
had a low TSH ( p< 0.01), suggesting that racial differences
may have a different set point for normal thyroid function (55).
Low TSH concentrations might return to normal spontane-
ously, but generally about half of all cases with subclinical
hyperthyroidism may have an increased risk of developing
overt hyperthyroidism over time (56). Hyperthyroidism has
been previously observed following iodine repletion in iodine-
deficient individuals, and iodine-induced hyperthyroidism
(IIH) is a recognized effect following the initiation of salt
iodization (57–59). In such areas, the WHO recommends a
lowered threshold for iodine excess equivalent to a median
UIC of 200lg/L in SAC (4). In the present study populations,
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acute IIH is unlikely due to the high naturally occurring water
iodine concentrations and the longevity of the USI programs in
both countries.
Excess iodine intake has also been associated with sub-
clinical and overt hypothyroidism following acute iodine
excess or in individuals with autoimmune thyroiditis exposed
to chronic high iodine intake (9,16), but this association is not
confirmed by the current data. A possible explanation may be
preservation of thyroid function due to the markedly elevated
Tg promoting the adaptive mechanisms, as discussed above.
PW and the developing fetus may be vulnerable to iodine
in excess (4,37,60–62), though the implications of iodine
excess during pregnancy are poorly understood, and data are
conflicting. Maternal hormone supply is critical for fetal
development, particularly in the first and second trimesters
(63). Supply must cover maternal and fetal needs throughout
gestation. The fetal thyroid is formed at gestational week 12,
organification possible after week 16–20 (64), and, perhaps
most importantly here, the Wolff–Chaikoff effect is not
functional until week 36 (65). Despite high iodine intake, PW
in this study were overall euthyroid, except for maternal
hypothyroxinemia (10% and 15% prevalence in Kenya and
Tanzania, respectively), which was positively correlated with
trimester ( p< 0.05). Tg was similarly positively correlated
with gestational age, suggesting increased thyroid activity,
possibly affecting T4 excretion. Hypothyroxinemia during
pregnancy has been linked with adverse birth outcomes, in-
cluding preterm delivery (66) and possibly irreversible low
childhood IQ (67–70). The present finding is in agreement
with a recent Chinese study reporting an almost threefold in-
creased risk of hypothyroxinemia in PW with UIC ‡500lg/L
compared to women with lower intake (n= 7190; p< 0.05) (3).
Iron deficiency, prevalent in both Kenya and Tanzania (24,29),
is another risk factor for hypothyroxinemia (69). In infants, the
estimated iodine intake exceeded the tolerable upper limits of
200lg/day (37), and the Tg concentration was markedly ele-
vated. Although infants may be particularly vulnerable to ex-
cessive iodine intake (7,65,71), no thyroid dysfunction was
observed in this study, suggesting that the infant thyroid may
adapt to high iodine intake when chronic. However, the long-
term consequences of thyroidal stress during infancy are un-
certain, and the results conflict with findings elsewhere
(10,72,73). Long-term follow-up of infants exposed to exces-
sive iodine intake for long periods is required.
A strength of this study is its comprehensive assessment of
iodine and thyroid status in a large sample of six life-stage
groups using standardized methods. Iodine intake was esti-
mated using dietary excretion assessed by spot urine samples
and an estimated fixed urine volume. Creatinine was not
measured, and the study did not correct for hydration status.
Despite the large overall sample size of this study, recruitment
was slower than expected in Kenya, and the desired number of
PW, lactating women, and breast-feeding infants could not be
reached within the recruitment period. Other reasons for a
lower sample size in these groups include withdrawal fol-
lowing consent. A limitation of the study is that older adults
were not included, who are considered at highest risk for
subclinical or overt thyroid disease (16). Also, antithyroid
antibodies were not measured. Positive titers of thyroid anti-
bodies have been identified as a risk factor for the development
of morbidity in genetically susceptible individuals with in-
creasing iodine intake (16,74). Though the questionnaire sur-
veyed general dietary intake of native iodine-rich and iodine-
fortified foods, processed or pre-prepared foods containing
iodized salt, knowledge and use of iodized salt, and source of
household water, this could not be used to quantify dietary
intake from dietary sources. Bouillon containing iodized salt
was widely available, but its potential contribution together
with iodized salt (75) was not measured.
In conclusion, chronic excess iodine intake was observed
in three study sites in Eastern Africa. Although Tg concen-
trations were elevated in all studied population groups, thy-
roid dysfunction was rare. The data confirm that populations
can generally adapt well to high intake of iodine, and the
findings are important because potentially vulnerable popu-
lation groups were examined early in the life cycle. High
iodine intake in these areas likely arises from a combination
of salt iodine concentrations above recommended levels,
excessive salt consumption, and groundwater that is high in
iodine. Enforcement of salt iodine standards combined with
regular monitoring of iodine status is critical to ensure opti-
mal iodine intake. Monitoring and surveillance should be
based primarily on UIC in conjunction with measuring salt
iodine concentrations. Where intake is elevated and salt
found to be over-iodized, excessive salt iodine concentrations
should be adjusted and adapted with respect to the current
average daily salt intake and the national salt iodization
standard. Drinking water should be considered as a potential
route of dietary iodine where intake greatly exceeds those
expected from iodized salt.
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